MedPath

Clinical study of Siddha drug MADHUMEGA KUDINEER (Internal) in the treatment of SINAIPAINEERKATTI

Phase 2
Completed
Conditions
Health Condition 1: null- Patients with the symptoms of Irregular menstrual cycle, hirsutism, obesity, polycystic changes in ovaries
Registration Number
CTRI/2017/07/008965
Lead Sponsor
Self
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

1.Patients who are having the clinical symptoms of Oligomenorrhoea (or) Amenorrhoea (or) obesity or infertility with polycystic changes in ovaries.

2.USG pelvis showing polycystic ovaries.

3.Patient willing to participate in trial and signing in consent form

Exclusion Criteria

1.H/O hypertension

2.Ovarian cancer

3.Pregnancy and lactation

4.H/O thyroid dysfunction

5.Patient with any serious illness

6.Fibroid uterus

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Regular menstrual cycle. <br/ ><br>2.Reduction in BMI <br/ ><br>Timepoint: 90 Days <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Changes in the polycystic appearance of the ovaries in USG pelvis and reduction of other symptoms such as Obesity, infertility, etc.Timepoint: 90 Days
© Copyright 2025. All Rights Reserved by MedPath